1786: SciVision Biotech Inc. - Summary | Jitta

SciVision Biotech Inc.

TWN:1786

Price
NT$57.50
Loss Chance
49.2%
4.53JITTA SCORE
71.23%Over Jitta Line
Jitta Ranking
558 / 1,077
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (49)
Recent Business Performance (31)
Financial Strength (86)
Return to Shareholders (23)
Competitive Advantage (41)
Jitta Signs
Revenue and EarningConsistent
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Operating MarginDeclined
Recent Business PerformanceEarning decline 33.45% in the last year
SG&A to SalesIncreasing Every Year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.53
71.23%
3.79
645.83%
Health Care Supplies
3.16
20.30%
6.62
44.93%
5.49
15.41%
COMPANY DESCRIPTION
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.